Figure 11.
Different patterns of Ki-67 immunoreactivity in the colonic mucosa of control mice (A), dinitrobenzene sulfonic acid (DNBS)-treated mice (B) and mice treated with DNBS plus cannabichromene (C). (A) Ki-67 immunopositive cells localized to the lower of the crypts. (B) Ki-67 immunoreactivity was observed on inflammatory cells. (C) Ki-67 immunopositive cells observed only in the expanded basal zone. CBC (1 mg·kg−1) was administered (i.p.) for 2 consecutive days starting 24 h after the inflammatory insult. The figure is representative of three experiments.